Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers

Experimental and Molecular Medicine

Volumn 40, Issue 6, 2008, Pages 677-685

  Won, Kon Kim ^a   Hwang, Hyang Ran ^a   Do, Hyung Kim ^a   Phil, Young Lee ^a   Yu, Jung In ^a   Ryu, Hye Young ^b   Sung, Goo Park ^a   Bae, Kwang Hee ^a   Sang, Chul Lee ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Sun General Hospital   (South Korea)

Author keywords

Apolipoproteins E; CD5L protein, human; Dermatitis, atopic; Glycoproteins; Plasma; Proteomics

Indexed keywords

APOLIPOPROTEIN E; CD5L PROTEIN; GLYCOPROTEIN; PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; BLOOD ANALYSIS; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN ANALYSIS; PROTEOMICS; UPREGULATION;

EID: 61849102357     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2008.40.6.677     Document Type: Article

References (32)

1. Abramotiv W. Atopic dermatitis. J Am Acad Dermatol 2005;53:86-93
2. Baumann MA, Paul CC. The AML14 and AML14.3D10 cell lines: a long-overdue model for the study of eosinophils and more. Stem Cells 1998;16:16-24
3. Domae M, Sagara H, Sakaue M, Fukuda T, Kamikawa Y. The antiallergic drug oxatomide promotes human eosinophil apoptosis and suppresses IL-5-induced eosinophil survival. J Allerg Clin Immunol 2003;111:567-72
4. Gangadharan B, Antrobus R, Dwek RA, Zitzmann N. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem 2007;53:1792-9
5. Gold MS, Kemp AS. Atopic disease in childhood. Med J Aust 2005;182:298-304
6. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331
7. Hanaffin JM, Rajka G. Diagnostic feature of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-7
8. Haruta I, Kato Y, Hashimoto E, Minjares C, Kennedy S, Uto H, Yamauchi K, Kobayashi M, Yusa S, Muller U, Hayashi N, Miyazaki T. Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages. J Biol Chem 2001;276:22910-4
9. Kang TH, Bae K-H, Yu M-j, Kim WK, Hwang H-R, Jung H, Lee PY, Kang S, Yoon T-S, Park SG, Ryu SE, Lee SC. Phosphoproteomic analysis of neuronal cell death by glutamate-induced oxidative stress. Proteomics 2007;7:2624-35
10. Kang S, Kim EY, Bahn YJ, Chung JW, Lee DH, Park SG, Yoon T-S, Park BC, Bae K-H. A proteomic analysis of the effect of MAPK pathway activation on L-glutamate-induced neuronal cell death. Cell Mol Biol Lett 2007;12:139-47
11. Kim YJ, Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 1997;14:569-76
12. Kim Y-S, Hwang SY, Oh S, Sohn H, Kang HY, Lee JH, Cho EW, Kim JY, Yoo JS, Kim CH, Miyoshi E, Taniguchi N, Ko JH. Identification of target proteins of N-acetylglucosaminyltransferase V and fucosyltransferase 8 in human gastric tissues by glycomic approach. Proteomics 2004;4:3353-8
13. Kuwata K, Watanabe H, Jiang SY, Yamamoto T, Tomiyama-Miyaji C, Abo T, Miyazaki T, Naito M. AIM inhibits apoptosis of T cells and NKT cells in Corynebacterium-induced granuloma formation in mice. Am J Pathol 2003;162:837-47
14. Lee EJ, Kim SH, Kwak YE, Kim J. Heterogeneous nuclear ribonuclear protein C is increased in the celecoxib-induced growth inhibition of human oral squamous cell carcinoma. Exp Mol Med 2006;38:203-9
15. Lee Y, Park H-W, Park SG, Cho S, Park BC, Lee DH. Proteomic analysis of glutamate-induced toxicity in HT22 cells. Proteomics 2007;7:185-93
16. Lovestone S, Guntert A, Hye A, Lynham S, Thambisetty M, Ward M. Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers. Expert Rev Proteomics 2007;4:227-38
17. Oldhoff JM, Darsow U, Werfel T, Katzer K, Wulf A, Laifaoui J, Hijnen DJ, Plotz S, Knol EF, Kapp A, Bruijnzeel-Koomen CA, Ring J, de Bruin-Weller MS. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy 2005;60:693-6
18. Ripolles Piquer B, Nazih H, Bourreille A, Segain JP, Huvelin JM, Galmiche JP, Bard JM. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism 2006;55:980-8
19. Ryu SI, Kim WK, Cho HJ, Lee PY, Jung H, Yoon TS, Moon JH, Kang S, Poo H, Bae KH, Lee SC. Phosphoproteomic analysis of AML14.3D10 cell line as a model system of eosinophilia. J Biochem Mol Biol 2007;40:765-72
20. Sarrias MR, Padilla O, Monreal Y, Carrascal M, Abian J, Vivers J, Yelamos J, Lozano F. Biochemical characterization of recombinant and circulating human Spα. Tissue Antigens 2004;63:335-44
21. Sarrias MR, Rosello S, Sanchez-Barbero F, Sierra JM, Vila J, Yelamos J, Casals C, Lozano F. A role for human Spα as a pattern recognition receptor. J Biol Chem 2005;280:35391-98
22. Scirica CV, Gold DR, Ryan L, Abulkerim H, Celedon JC, Platts-Mills TA, Naccara LM, Weiss ST, Litonjua AA. Predictors of cord blood IgE levels in children at risk for asthma and atopy. J Allergy Clin Immunol 2007;119:81-8
23. Simon D, Braathen LR, Simon H-U. Eosinophils and atopic dermatitis. Allergy 2004;59:561-70
24. Simon D, Simon H-U. Eosinophilic disorders. J Allergy Clin Immunol 2007;119:1291-300
25. Simon HU. Regulation of apoptosis in diseases associated with eosinophilia. Resp Med 2000;94:1258-9
26. Trautmann A, Akdis M, Blaser K, Akdis CA. Role of dysregulated apoptosis in atopic dermatitis. Apoptosis 2000;5:425-9
27. Trautmann A, Akdis M, Klunker S, Blaser K, Akdis CA. Role of apoptosis in atopic dermatitis. Int Arch Aller Immunol 2001;124:230-2
28. Wu J, Kobayashi M, Sousa EA, Liu W, Cai J, Goldman SJ, Dorner AJ, Projan SJ, Kavuru MS, Qiu Y, Thomassen MJ. Mol Cell Proteomics 2005;4:1251-64
29. Yoon SW, Kim TY, Sung MH, Kim CJ, Poo H. Comparative proteomic analysis of peripheral blood eosinophils from healthy donors and atopic dermatitis patients with eosinophilia. Proteomics 2005;5:1987-95
30. Yuk JS, Ha KS. Proteomic applications of surface plasmon resonance biosensors: analysis of protein arrays. Exp Mol Med 2005;37:1-10
31. Yusa S, Ohnishi S, Onodera T, Miyazaki T. AIM, a murine apoptosis inhibitory factor, induces strong and sustained growth inhibition of B lymphocytes in combination with TGF-β1. Eur J Immunol 1998;29:1086-93
32. Zhao J, Simeone DM, Heidt D, Anderson MA, Lubman DM. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J Proteome Res 2006;5:1792-802